PPARA and neoplasm: Neutrophils with antiangiogenic features have been reported to be able to release the endogenous angiogenesis inhibitor thrombospondin-1 in peroxisome proliferator-activated receptor (PPAR)α-deficient mice, thus preventing angiogenesis and tumor growth (92).